img

Global Meningitis Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Meningitis Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Meningitis Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Meningitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Meningitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Meningitis Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Meningitis Vaccine include GlaxoSmithKline, Baxter International, Sanofi Pasteur, Merck, Novartis, Pfizer, Hualan, Zhejiang Tianyuan and Beijing Tiantan Biological, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Meningitis Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Meningitis Vaccine by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Meningitis Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Meningitis Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


GlaxoSmithKline
Baxter International
Sanofi Pasteur
Merck
Novartis
Pfizer
Hualan
Zhejiang Tianyuan
Beijing Tiantan Biological
By Type
Meningitis A+C
Meningitis ACWY135
Meningitis B
By Application
Medical Care
Hospital
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Meningitis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Meningitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meningitis Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Meningitis Vaccine Definition
1.2 Market by Type
1.2.1 Global Meningitis Vaccine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Meningitis A+C
1.2.3 Meningitis ACWY135
1.2.4 Meningitis B
1.3 Market Segment by Application
1.3.1 Global Meningitis Vaccine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Medical Care
1.3.3 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Meningitis Vaccine Sales
2.1 Global Meningitis Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Meningitis Vaccine Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Meningitis Vaccine Revenue by Region
2.3.1 Global Meningitis Vaccine Revenue by Region (2018-2023)
2.3.2 Global Meningitis Vaccine Revenue by Region (2024-2034)
2.4 Global Meningitis Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Meningitis Vaccine Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Meningitis Vaccine Sales Quantity by Region
2.6.1 Global Meningitis Vaccine Sales Quantity by Region (2018-2023)
2.6.2 Global Meningitis Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Meningitis Vaccine Sales Quantity by Manufacturers
3.1.1 Global Meningitis Vaccine Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Meningitis Vaccine Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Meningitis Vaccine Sales in 2024
3.2 Global Meningitis Vaccine Revenue by Manufacturers
3.2.1 Global Meningitis Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Meningitis Vaccine Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Meningitis Vaccine Revenue in 2024
3.3 Global Meningitis Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Meningitis Vaccine, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Meningitis Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Meningitis Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Meningitis Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Meningitis Vaccine Sales Quantity by Type
4.1.1 Global Meningitis Vaccine Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Meningitis Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Meningitis Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Meningitis Vaccine Revenue by Type
4.2.1 Global Meningitis Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Meningitis Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Meningitis Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Meningitis Vaccine Price by Type
4.3.1 Global Meningitis Vaccine Price by Type (2018-2023)
4.3.2 Global Meningitis Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Meningitis Vaccine Sales Quantity by Application
5.1.1 Global Meningitis Vaccine Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Meningitis Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Meningitis Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Meningitis Vaccine Revenue by Application
5.2.1 Global Meningitis Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Meningitis Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Meningitis Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Meningitis Vaccine Price by Application
5.3.1 Global Meningitis Vaccine Price by Application (2018-2023)
5.3.2 Global Meningitis Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Meningitis Vaccine Sales by Company
6.1.1 North America Meningitis Vaccine Revenue by Company (2018-2023)
6.1.2 North America Meningitis Vaccine Sales Quantity by Company (2018-2023)
6.2 North America Meningitis Vaccine Market Size by Type
6.2.1 North America Meningitis Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Meningitis Vaccine Revenue by Type (2018-2034)
6.3 North America Meningitis Vaccine Market Size by Application
6.3.1 North America Meningitis Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Meningitis Vaccine Revenue by Application (2018-2034)
6.4 North America Meningitis Vaccine Market Size by Country
6.4.1 North America Meningitis Vaccine Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Meningitis Vaccine Revenue by Country (2018-2034)
6.4.3 North America Meningitis Vaccine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Meningitis Vaccine Sales by Company
7.1.1 Europe Meningitis Vaccine Sales Quantity by Company (2018-2023)
7.1.2 Europe Meningitis Vaccine Revenue by Company (2018-2023)
7.2 Europe Meningitis Vaccine Market Size by Type
7.2.1 Europe Meningitis Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Meningitis Vaccine Revenue by Type (2018-2034)
7.3 Europe Meningitis Vaccine Market Size by Application
7.3.1 Europe Meningitis Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Meningitis Vaccine Revenue by Application (2018-2034)
7.4 Europe Meningitis Vaccine Market Size by Country
7.4.1 Europe Meningitis Vaccine Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Meningitis Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Meningitis Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Meningitis Vaccine Sales by Company
8.1.1 China Meningitis Vaccine Sales Quantity by Company (2018-2023)
8.1.2 China Meningitis Vaccine Revenue by Company (2018-2023)
8.2 China Meningitis Vaccine Market Size by Type
8.2.1 China Meningitis Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Meningitis Vaccine Revenue by Type (2018-2034)
8.3 China Meningitis Vaccine Market Size by Application
8.3.1 China Meningitis Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Meningitis Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Meningitis Vaccine Sales by Company
9.1.1 APAC Meningitis Vaccine Sales Quantity by Company (2018-2023)
9.1.2 APAC Meningitis Vaccine Revenue by Company (2018-2023)
9.2 APAC Meningitis Vaccine Market Size by Type
9.2.1 APAC Meningitis Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Meningitis Vaccine Revenue by Type (2018-2034)
9.3 APAC Meningitis Vaccine Market Size by Application
9.3.1 APAC Meningitis Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Meningitis Vaccine Revenue by Application (2018-2034)
9.4 APAC Meningitis Vaccine Market Size by Region
9.4.1 APAC Meningitis Vaccine Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Meningitis Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Meningitis Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Meningitis Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Meningitis Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Meningitis Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Meningitis Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 GlaxoSmithKline Meningitis Vaccine Products and Services
11.1.5 GlaxoSmithKline Meningitis Vaccine SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Baxter International
11.2.1 Baxter International Company Information
11.2.2 Baxter International Overview
11.2.3 Baxter International Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Baxter International Meningitis Vaccine Products and Services
11.2.5 Baxter International Meningitis Vaccine SWOT Analysis
11.2.6 Baxter International Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Company Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Sanofi Pasteur Meningitis Vaccine Products and Services
11.3.5 Sanofi Pasteur Meningitis Vaccine SWOT Analysis
11.3.6 Sanofi Pasteur Recent Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Overview
11.4.3 Merck Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Merck Meningitis Vaccine Products and Services
11.4.5 Merck Meningitis Vaccine SWOT Analysis
11.4.6 Merck Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Novartis Meningitis Vaccine Products and Services
11.5.5 Novartis Meningitis Vaccine SWOT Analysis
11.5.6 Novartis Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Pfizer Meningitis Vaccine Products and Services
11.6.5 Pfizer Meningitis Vaccine SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Hualan
11.7.1 Hualan Company Information
11.7.2 Hualan Overview
11.7.3 Hualan Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Hualan Meningitis Vaccine Products and Services
11.7.5 Hualan Meningitis Vaccine SWOT Analysis
11.7.6 Hualan Recent Developments
11.8 Zhejiang Tianyuan
11.8.1 Zhejiang Tianyuan Company Information
11.8.2 Zhejiang Tianyuan Overview
11.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Zhejiang Tianyuan Meningitis Vaccine Products and Services
11.8.5 Zhejiang Tianyuan Meningitis Vaccine SWOT Analysis
11.8.6 Zhejiang Tianyuan Recent Developments
11.9 Beijing Tiantan Biological
11.9.1 Beijing Tiantan Biological Company Information
11.9.2 Beijing Tiantan Biological Overview
11.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Beijing Tiantan Biological Meningitis Vaccine Products and Services
11.9.5 Beijing Tiantan Biological Meningitis Vaccine SWOT Analysis
11.9.6 Beijing Tiantan Biological Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Meningitis Vaccine Value Chain Analysis
12.2 Meningitis Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meningitis Vaccine Production Mode & Process
12.4 Meningitis Vaccine Sales and Marketing
12.4.1 Meningitis Vaccine Sales Channels
12.4.2 Meningitis Vaccine Distributors
12.5 Meningitis Vaccine Customers
13 Market Dynamics
13.1 Meningitis Vaccine Industry Trends
13.2 Meningitis Vaccine Market Drivers
13.3 Meningitis Vaccine Market Challenges
13.4 Meningitis Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Meningitis Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Meningitis A+C
Table 3. Major Manufacturers of Meningitis ACWY135
Table 4. Major Manufacturers of Meningitis B
Table 5. Global Meningitis Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Meningitis Vaccine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Meningitis Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Meningitis Vaccine Revenue Market Share by Region (2018-2023)
Table 9. Global Meningitis Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Meningitis Vaccine Revenue Market Share by Region (2024-2034)
Table 11. Global Meningitis Vaccine Sales Quantity by Region: 2018 VS 2024 VS 2034 (K MT)
Table 12. Global Meningitis Vaccine Sales by Region (2018-2023) & (K MT)
Table 13. Global Meningitis Vaccine Sales Market Share by Region (2018-2023)
Table 14. Global Meningitis Vaccine Sales by Region (2024-2034) & (K MT)
Table 15. Global Meningitis Vaccine Sales Market Share by Region (2024-2034)
Table 16. Global Meningitis Vaccine Sales Quantity by Manufacturers (2018-2023) & (K MT)
Table 17. Global Meningitis Vaccine Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Meningitis Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Meningitis Vaccine Revenue Share by Manufacturers (2018-2023)
Table 20. Global Meningitis Vaccine Price by Manufacturers 2018-2023 (USD/MT)
Table 21. Global Key Players of Meningitis Vaccine, Industry Ranking, 2021 VS 2024
Table 22. Global Meningitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningitis Vaccine as of 2024)
Table 24. Global Key Manufacturers of Meningitis Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Meningitis Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Meningitis Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Meningitis Vaccine Sales Quantity by Type (2018-2023) & (K MT)
Table 29. Global Meningitis Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 30. Global Meningitis Vaccine Sales Quantity Share by Type (2018-2023)
Table 31. Global Meningitis Vaccine Sales Quantity Share by Type (2024-2034)
Table 32. Global Meningitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Meningitis Vaccine Revenue Share by Type (2018-2023)
Table 35. Global Meningitis Vaccine Revenue Share by Type (2024-2034)
Table 36. Meningitis Vaccine Price by Type (2018-2023) & (USD/MT)
Table 37. Global Meningitis Vaccine Price Forecast by Type (2024-2034) & (USD/MT)
Table 38. Global Meningitis Vaccine Sales Quantity by Application (2018-2023) & (K MT)
Table 39. Global Meningitis Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 40. Global Meningitis Vaccine Sales Quantity Share by Application (2018-2023)
Table 41. Global Meningitis Vaccine Sales Quantity Share by Application (2024-2034)
Table 42. Global Meningitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Meningitis Vaccine Revenue Share by Application (2018-2023)
Table 45. Global Meningitis Vaccine Revenue Share by Application (2024-2034)
Table 46. Meningitis Vaccine Price by Application (2018-2023) & (USD/MT)
Table 47. Global Meningitis Vaccine Price Forecast by Application (2024-2034) & (USD/MT)
Table 48. North America Meningitis Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Meningitis Vaccine Sales Quantity by Company (2018-2023) & (K MT)
Table 50. North America Meningitis Vaccine Sales Quantity by Type (2018-2023) & (K MT)
Table 51. North America Meningitis Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 52. North America Meningitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Meningitis Vaccine Sales Quantity by Application (2018-2023) & (K MT)
Table 55. North America Meningitis Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 56. North America Meningitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Meningitis Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Meningitis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Meningitis Vaccine Sales Quantity by Country (2018-2023) & (K MT)
Table 62. North America Meningitis Vaccine Sales Quantity by Country (2024-2034) & (K MT)
Table 63. Europe Meningitis Vaccine Sales Quantity by Company (2018-2023) & (K MT)
Table 64. Europe Meningitis Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Meningitis Vaccine Sales Quantity by Type (2018-2023) & (K MT)
Table 66. Europe Meningitis Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 67. Europe Meningitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Meningitis Vaccine Sales Quantity by Application (2018-2023) & (K MT)
Table 70. Europe Meningitis Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 71. Europe Meningitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Meningitis Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Meningitis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Meningitis Vaccine Sales Quantity by Country (2018-2023) & (K MT)
Table 77. Europe Meningitis Vaccine Sales Quantity by Country (2024-2034) & (K MT)
Table 78. China Meningitis Vaccine Sales Quantity by Company (2018-2023) & (K MT)
Table 79. China Meningitis Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Meningitis Vaccine Sales Quantity by Type (2018-2023) & (K MT)
Table 81. China Meningitis Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 82. China Meningitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Meningitis Vaccine Sales Quantity by Application (2018-2023) & (K MT)
Table 85. China Meningitis Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 86. China Meningitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Meningitis Vaccine Sales Quantity by Company (2018-2023) & (K MT)
Table 89. APAC Meningitis Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Meningitis Vaccine Sales Quantity by Type (2018-2023) & (K MT)
Table 91. APAC Meningitis Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 92. APAC Meningitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Meningitis Vaccine Sales Quantity by Application (2018-2023) & (K MT)
Table 95. APAC Meningitis Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 96. APAC Meningitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Meningitis Vaccine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Meningitis Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Meningitis Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Meningitis Vaccine Sales Quantity by Region (2018-2023) & (K MT)
Table 102. APAC Meningitis Vaccine Sales Quantity by Region (2024-2034) & (K MT)
Table 103. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Company (2018-2023) & (K MT)
Table 104. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Type (2018-2023) & (K MT)
Table 106. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 107. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Application (2018-2023) & (K MT)
Table 110. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 111. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Country (2018-2023) & (K MT)
Table 117. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity by Country (2024-2034) & (K MT)
Table 118. GlaxoSmithKline Company Information
Table 119. GlaxoSmithKline Description and Overview
Table 120. GlaxoSmithKline Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 121. GlaxoSmithKline Meningitis Vaccine Product and Services
Table 122. GlaxoSmithKline Meningitis Vaccine SWOT Analysis
Table 123. GlaxoSmithKline Recent Developments
Table 124. Baxter International Company Information
Table 125. Baxter International Description and Overview
Table 126. Baxter International Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 127. Baxter International Meningitis Vaccine Product and Services
Table 128. Baxter International Meningitis Vaccine SWOT Analysis
Table 129. Baxter International Recent Developments
Table 130. Sanofi Pasteur Company Information
Table 131. Sanofi Pasteur Description and Overview
Table 132. Sanofi Pasteur Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 133. Sanofi Pasteur Meningitis Vaccine Product and Services
Table 134. Sanofi Pasteur Meningitis Vaccine SWOT Analysis
Table 135. Sanofi Pasteur Recent Developments
Table 136. Merck Company Information
Table 137. Merck Description and Overview
Table 138. Merck Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 139. Merck Meningitis Vaccine Product and Services
Table 140. Merck Meningitis Vaccine SWOT Analysis
Table 141. Merck Recent Developments
Table 142. Novartis Company Information
Table 143. Novartis Description and Overview
Table 144. Novartis Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 145. Novartis Meningitis Vaccine Product and Services
Table 146. Novartis Meningitis Vaccine SWOT Analysis
Table 147. Novartis Recent Developments
Table 148. Pfizer Company Information
Table 149. Pfizer Description and Overview
Table 150. Pfizer Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 151. Pfizer Meningitis Vaccine Product and Services
Table 152. Pfizer Meningitis Vaccine SWOT Analysis
Table 153. Pfizer Recent Developments
Table 154. Hualan Company Information
Table 155. Hualan Description and Overview
Table 156. Hualan Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 157. Hualan Meningitis Vaccine Product and Services
Table 158. Hualan Meningitis Vaccine SWOT Analysis
Table 159. Hualan Recent Developments
Table 160. Zhejiang Tianyuan Company Information
Table 161. Zhejiang Tianyuan Description and Overview
Table 162. Zhejiang Tianyuan Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 163. Zhejiang Tianyuan Meningitis Vaccine Product and Services
Table 164. Zhejiang Tianyuan Meningitis Vaccine SWOT Analysis
Table 165. Zhejiang Tianyuan Recent Developments
Table 166. Beijing Tiantan Biological Company Information
Table 167. Beijing Tiantan Biological Description and Overview
Table 168. Beijing Tiantan Biological Meningitis Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 169. Beijing Tiantan Biological Meningitis Vaccine Product and Services
Table 170. Beijing Tiantan Biological Meningitis Vaccine SWOT Analysis
Table 171. Beijing Tiantan Biological Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Meningitis Vaccine Distributors List
Table 175. Meningitis Vaccine Customers List
Table 176. Meningitis Vaccine Market Trends
Table 177. Meningitis Vaccine Market Drivers
Table 178. Meningitis Vaccine Market Challenges
Table 179. Meningitis Vaccine Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningitis Vaccine Product Picture
Figure 2. Global Meningitis Vaccine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Meningitis Vaccine Market Share by Type in 2024 & 2034
Figure 4. Meningitis A+C Product Picture
Figure 5. Meningitis ACWY135 Product Picture
Figure 6. Meningitis B Product Picture
Figure 7. Global Meningitis Vaccine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Meningitis Vaccine Market Share by Application in 2024 & 2034
Figure 9. Medical Care
Figure 10. Hospital
Figure 11. Meningitis Vaccine Report Years Considered
Figure 12. Global Meningitis Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Meningitis Vaccine Revenue 2018-2034 (US$ Million)
Figure 14. Global Meningitis Vaccine Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 15. Global Meningitis Vaccine Sales Quantity 2018-2034 (K MT)
Figure 16. Global Meningitis Vaccine Sales Quantity Market Share by Region (2018-2023)
Figure 17. Global Meningitis Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Meningitis Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 19. North America Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Meningitis Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 21. Europe Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Meningitis Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 23. China Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Meningitis Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 25. APAC Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 27. Middle East, Africa and Latin America Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Meningitis Vaccine Sales Quantity in 2024
Figure 29. The Top 10 and Top 5 Players Market Share by Meningitis Vaccine Revenue in 2024
Figure 30. Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 31. Global Meningitis Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 33. Global Meningitis Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 35. North America Meningitis Vaccine Revenue Market Share by Company in 2024
Figure 36. North America Meningitis Vaccine Sales Quantity Market Share by Company in 2024
Figure 37. North America Meningitis Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 39. North America Meningitis Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 41. North America Meningitis Vaccine Revenue Share by Country (2018-2034)
Figure 42. North America Meningitis Vaccine Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Meningitis Vaccine Sales Quantity Market Share by Company in 2024
Figure 46. Europe Meningitis Vaccine Revenue Market Share by Company in 2024
Figure 47. Europe Meningitis Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 49. Europe Meningitis Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 51. Europe Meningitis Vaccine Revenue Share by Country (2018-2034)
Figure 52. Europe Meningitis Vaccine Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 54. France Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. China Meningitis Vaccine Sales Quantity Market Share by Company in 2024
Figure 59. China Meningitis Vaccine Revenue Market Share by Company in 2024
Figure 60. China Meningitis Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 62. China Meningitis Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 64. APAC Meningitis Vaccine Sales Quantity Market Share by Company in 2024
Figure 65. APAC Meningitis Vaccine Revenue Market Share by Company in 2024
Figure 66. APAC Meningitis Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 68. APAC Meningitis Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 70. APAC Meningitis Vaccine Revenue Share by Region (2018-2034)
Figure 71. APAC Meningitis Vaccine Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. India Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Meningitis Vaccine Revenue Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Meningitis Vaccine Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Meningitis Vaccine Revenue Share by Country (2018-2034)
Figure 85. Brazil Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 90. Meningitis Vaccine Value Chain
Figure 91. Meningitis Vaccine Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries